Status:
COMPLETED
The Role of Circulating Soluble CD74 in Acute Lung Injury
Lead Sponsor:
Changhai Hospital
Conditions:
Acute Lung Injury
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
16-100 years
Brief Summary
Efforts to identify circulating factors that predict severity of acute lung injury/acute respiratory distress syndrome（ALI/ARDS） patients is unrevealing. The primary purpose of this study is to verify...
Detailed Description
Acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) is a devastating cause of morbidity and mortality characterized by alveolar epithelial and endothelial injury. Despite recent adva...
Eligibility Criteria
Inclusion
- Clinical diagnosis of ALI/ARDS
- Informed consent was obtained from either the subjects themselves or from designated surrogates before enrollment in the study.
Exclusion
- Patients who have chronic lung disease before enrollment.
- Patients who have severe organ dysfunction, autoimmune diseases and tumor.
- Women who are pregnant or breast-feeding.
- Patients who, in the opinion of the Investigator, have any other medical condition which renders the patient unable to complete the study or which would interfere with optimal participation in the study or produce significant risk to the patient.
- Patients participating in or planning to enroll in another clinical trial during the time of the study.
Key Trial Info
Start Date :
March 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT02201446
Start Date
March 1 2014
End Date
April 1 2015
Last Update
February 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Burn and Trauma Sugery, Changhai Hospital
Shanghai, China, 200433